Jennison Associates’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Jennison Associates’s Portfolio LBPH Stock Details LBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-917,528	Closed	-$30.6M	–	642
2024 Q3	$30.6M	Sell	917,528 -34,440	-4%	-$1.19M	0.02%	296
2024 Q2	$25.7M	Buy	951,968 +9,564	+1%	+$189K	0.02%	306
2024 Q1	$20.4M	Buy	942,404 +461,576	+96%	+$10.1M	0.01%	340
2023 Q4	$2.9M	Buy	+480,828	New	+$2.4M	﹤0.01%	440

Jennison Associates's LBPH Position: Q4 2024 in Review

Jennison Associates sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 917,528 shares — an estimated $30.6M sold.

Jennison Associates first reported a position in LBPH in Q4 2023 and held it in 4 quarters. The position peaked at $30.6M in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

Jennison Associates reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Jennison Associates sold 917,528 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $30.6M.
Jennison Associates first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q4 2023 and held it in 4 quarters.
Jennison Associates's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $30.6M in Q3 2024.
0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Jennison Associates's 13F filing for Q4 2024, filed 24 Jan 2025.